Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
| 适应症 | Obesity, Type2 Diabetes, Bariatric Surgery Candidate |
|---|---|
| 分期 | 不适用 |
| 申办方 | The Cleveland Clinic |
| 状态 | 已完成 |
| 受试者人数 | 91,700 人 |
| 干预（药物） | Bariatric Surgery |
| 开始日期 | 2019年6月5日 |
| 完成日期 | 2019年7月12日 |
| 结果公布日 | 2026年8月3日 |
摘要
The objective of the analysis was to evaluate the relationship between bariatric surgery and cardiovascular outcomes in obese patients with type 2 diabetes.
All-Cause Mortality and/or Cardiovascular Outcomes
| Bariatric Surgery | 30.8 percentage of participants |
|---|---|
| Non-Surgical Control | 47.7 percentage of participants |
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Uric Acid Lowering Trial in Youth Onset T2D — University of Colorado, Denver
- Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1 — State University of New York at Buffalo
- Continuous Glucose Monitoring Following Hospital Discharge — Kathleen Dungan
- Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on I — University of Colorado, Denver
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus — Eli Lilly and Company